BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 855 filers reported holding BAXTER INTL INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $355,000 | -4.3% | 4,405 | +0.0% | 0.02% | -8.3% |
| Q1 2021 | $371,000 | -41.4% | 4,403 | -44.2% | 0.02% | -45.5% |
| Q4 2020 | $633,000 | +1.0% | 7,892 | +1.2% | 0.04% | -10.2% |
| Q3 2020 | $627,000 | -33.2% | 7,800 | -28.5% | 0.05% | -41.0% |
| Q2 2020 | $939,000 | -81.0% | 10,911 | -78.4% | 0.08% | -57.4% |
| Q1 2020 | $4,948,000 | +400.8% | 50,555 | +328.0% | 0.20% | +121.6% |
| Q4 2019 | $988,000 | +1.1% | 11,813 | +5.7% | 0.09% | -8.3% |
| Q3 2019 | $977,000 | +10.4% | 11,173 | +3.4% | 0.10% | +6.7% |
| Q2 2019 | $885,000 | +15.5% | 10,809 | +14.8% | 0.09% | +8.4% |
| Q1 2019 | $766,000 | +30.7% | 9,416 | +5.8% | 0.08% | +6.4% |
| Q4 2018 | $586,000 | -17.7% | 8,903 | -3.6% | 0.08% | +6.8% |
| Q3 2018 | $712,000 | +4.4% | 9,237 | +0.0% | 0.07% | 0.0% |
| Q2 2018 | $682,000 | +6.1% | 9,235 | -6.6% | 0.07% | +2.8% |
| Q1 2018 | $643,000 | +13.0% | 9,887 | +12.2% | 0.07% | +12.7% |
| Q4 2017 | $569,000 | +7.6% | 8,810 | +0.8% | 0.06% | -7.4% |
| Q3 2017 | $529,000 | 0.0% | 8,738 | 0.0% | 0.07% | 0.0% |
| Q2 2017 | $529,000 | +31.9% | 8,738 | +12.9% | 0.07% | +15.3% |
| Q1 2017 | $401,000 | +9.6% | 7,737 | -6.4% | 0.06% | +5.4% |
| Q4 2016 | $366,000 | -6.9% | 8,263 | 0.0% | 0.06% | -13.8% |
| Q3 2016 | $393,000 | -68.2% | 8,263 | -69.8% | 0.06% | -68.8% |
| Q2 2016 | $1,237,000 | +9.2% | 27,363 | -0.8% | 0.21% | +1.0% |
| Q1 2016 | $1,133,000 | -24.9% | 27,587 | -30.2% | 0.21% | -36.8% |
| Q4 2015 | $1,508,000 | +6.6% | 39,533 | -8.2% | 0.33% | -8.2% |
| Q3 2015 | $1,414,000 | -34.2% | 43,044 | +40.0% | 0.36% | -37.7% |
| Q2 2015 | $2,150,000 | +2.6% | 30,747 | +0.5% | 0.57% | +1.4% |
| Q1 2015 | $2,096,000 | +203.8% | 30,594 | +225.1% | 0.56% | +194.2% |
| Q4 2014 | $690,000 | +41.1% | 9,410 | +38.2% | 0.19% | +28.2% |
| Q3 2014 | $489,000 | +19.0% | 6,807 | +19.8% | 0.15% | +8.0% |
| Q2 2014 | $411,000 | -67.9% | 5,682 | -67.3% | 0.14% | -70.0% |
| Q1 2014 | $1,280,000 | +14.5% | 17,390 | +8.2% | 0.46% | +3.1% |
| Q4 2013 | $1,118,000 | +211.4% | 16,074 | +193.8% | 0.45% | +173.6% |
| Q3 2013 | $359,000 | -5.3% | 5,472 | 0.0% | 0.16% | -14.2% |
| Q2 2013 | $379,000 | – | 5,472 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |